• Site Görseli

  • Site Görseli

  • Site Görseli

  • Site Görseli

  • Site Görseli

  • Site Görseli

Expert: New HIV/AIDS cases increased 70 percent in 2014

The number of people newly diagnosed with HIV/AIDS in Turkey increased to 1,700 in 2014, up from 1,000 in 2013, Professor Fehmi Tabak, a specialist...

IDWeek 2014: Hepatitis B Relapse Is Common After Stopping Antiviral Therapy

Hepatitis B virus (HBV) rebounded in nearly 80% of people treated with fully or partially suppressive antiviral therapy using adefovir (Hepsera),...

Entecavir and tenofovir both work well against hepatitis B in clinical practice

Entecavir (Baraclude) and tenofovir (Viread) both demonstrated potent activity against hepatitis B virus (HBV) in a Turkish study presented at the...

Entecavir, Tenofovir Comparable in Patients with Treatment-Naïve Chronic Hepatitis B

SAN FRANCISCO, CA—Third-year results of a “real-world” cohort study found the antivirals entecavir and tenofovir provided...

542449 people visited our site so far